Therapy of advanced gastrointestinal cancer with the nitrosoureas.

No abstract is available for this paper.

• Publication year

  1973

• Venue

  Cancer chemotherapy reports. Part 3

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 4748872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.

  1972cited by this paper
• Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037).

  1971cited by this paper
• Therapy of advanced gastrointestinal cancer with 1‐3‐bis‐(2‐chlorethyl)‐l‐nitrosourea (BCNU)

  1968cited by this paper

• A review of the mutagenic potential of N‐ethyl‐N‐nitrosourea (ENU) to induce hematological malignancies

  2022cites this paper
• Structure-Activity Studies of Methylnitrosourea Antitumor Agents with Reduced Murine Bone Marrow Toxicity1

  2006cites this paper
• LACK OF EFFECTIVENESS OF COMBINED ADVANCED COLORECTAL CANCER 5-FLUOROURACIL AND METHYL-CCNU THERAPY IN

  2006cites this paper
• Structure-Activity Studies of Methylnitrosourea Antitumor Agents with Reduced Murine Bone Marrow Toxicity 1

  2006cites this paper
• CHEMOTHERAPY OF HUMAN COLORECTAL TUMOR XENOGRAFTS IN ATHYMIC MICE WITH CLINICALLY ACTIVE DRUGS: NITROSOUREA (BCNU). COMPARISON WITH DOXORUBICIN DERIVATIVES: 5FLUOROURACILE AND 1-3-BIS-(-2-CHLOROETHYL)-l- 4'DEOXYDOXORUBICIN AND 4'-O-METHYLDOXORUBICIN

  2006cites this paper
• Ability of the a and ßAnomers of Chlorozotocin to Kill Rat 9L Tumor Cells in Vitro1

  2006cites this paper
• Phase I evaluation of chlorozotocin (NSC-178248): weekly schedule

  2004cites this paper
• Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice

  2004cites this paper
• Comparison of the transport of chlorozotocin and CCNU in L1210 leukemia and murine bone marrow cells in vitro

  2004cites this paper
• Chemotherapy options for gastric cancer.

  2002cites this paper
• The evolution of fluoropyrimidine therapy: from intravenous to oral.

  2001cites this paper
• Raltitrexed and the treatment of advanced colorectal cancer

  1996cites this paper
• Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro.

  1996cites this paper
• Randomized phase III Study of 5‐fluorouracil plus high dose folinic acid versus 5‐fluorouracil plus folinic acid plus methyl‐lomustine for patients with advanced colorectal cancer

  1995cites this paper
• An Eastern Cooperative Oncology Group phase II study of single agent DHAD, VP-16, aclacinomycin, or spirogermanium in metastatic pancreatic cancer.

  1994cites this paper
• Phase II study of cystemustine in metastatic colorectal carcinoma. A trial of the EORTC Clinical Screening Group.

  1993cites this paper
• Effect of O6-benzylguanine on the sensitivity of human colon tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).

  1993cites this paper
• Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.

  1993cites this paper
• Adjuvant systemic treatment for carcinoma of the colon and rectum.

  1991cites this paper
• Immunomodulatory effects of nitrosoureas on the phenotype and functions of T cells in the thymus and periphery.

  1990cites this paper
• Ability of the alpha and beta anomers of chlorozotocin to kill rat 9L tumor cells in vitro.

  1989cites this paper
• Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer.

  1989cites this paper
• Phase-II-study with EAP (etoposide, adriamycin, cis-platinum) in patients with primary inoperable gastric cancer and advanced disease.

  1988cites this paper
• Chemotherapy of gastric cancer

  1988cites this paper
• Antitumour activity of a new water-soluble nitrosoureido sugar: CY233 (NSC 609224).

  1988cites this paper
• Chemotherapy in gastrointestinal malignancies.

  1988cites this paper
• Multi-modality treatment of primary nonresectable intrahepatic cholangiocarcinoma with 131I anti-CEA--a Radiation Therapy Oncology Group Study.

  1987cites this paper
• Role of chemotherapy in the treatment of colorectal carcinoma.

  1987cites this paper
• Phase I clinical study of the new amino acid-linked nitrosourea, S 10036, administered on a weekly schedule.

  1987cites this paper
• Treatment of Advanced Colorectal Carcinoma with Actinomycin D, Vincristine, Methyl‐CCNU, and Methotrexate

  1987cites this paper
• Methyl‐CCNU and Methotrexate Therapy in Patients with Advanced Colorectal Cancer After Failure of 5‐Fluorouracil Chemotherapy

  1986cites this paper
• Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies.

  1986cites this paper
• Update in cancer chemotherapy: gastrointestinal cancer--colorectal cancer, Part 1.

  1986cites this paper
• Effect of alkylating drugs on rat cerebellum.

  1986cites this paper
• New cysteamine (2-chloroethyl)nitrosoureas. Synthesis and preliminary antitumor results.

  1985cites this paper
• Chemotherapy and combined modality therapy for locally advanced and metastatic gastric carcinoma.

  1985cites this paper
• Mechanism of action of 2-haloethylnitrosoureas on deoxyribonucleic acid. Pathways of aqueous decomposition and pharmacological characteristics of new anticancer disulfide-linked nitrosoureas.

  1985cites this paper
• Current status of chemotherapy for advanced pancreatic and gastric cancer.

  1985cites this paper
• [High-dose nitrosourea in a case of non-Hodgkin's lymphoma].

  1984cites this paper
• Biochemical and cytotoxic properties of the isomeric forms of N,N'-bis[N-2-chloroethyl)-N-nitrosocarbamoyl] cystamine.

  1984cites this paper
• A phase II study of chlorozotocin in advanced large bowel carcinoma: A cooperative study between two institutions

  1984cites this paper
• Chemotherapy for primary adenocarcinoma of the small bowel

  1984cites this paper
• Phase II trial of PCNU in advanced colorectal carcinoma An Eastern Cooperative Oncology Group pilot study

  1984cites this paper
• Chemotherapy of advanced colorectal carcinoma: Fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin A phase III trial by the Eastern Cooperative Oncology Group (EST 1278)

  1984cites this paper
• A phase II study of the combination, 1,3‐bis(2‐chloroethyl)‐1‐nitrosourea (BCNU) and N‐(phosphonacetyl)‐L‐aspartate (PALA), in patients with advanced large bowel cancer

  1984cites this paper
• Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.

  1983cites this paper
• Chemotherapy of large bowel cancer.

  1982cites this paper
• Correlation of nitrosourea murine bone marrow toxicity with deoxyribonucleic acid alkylation and chromatin binding sites.

  1982cites this paper
• Palliative and adjunctive measures in rectal cancer

  1982cites this paper
• Study of nitrosourea glycosyl analogs--V. An oriented phase II trial of RFCNU.

  1982cites this paper
• Toxicity of very high dose nitrosourea administration

  1982cites this paper
• Combination chemotherapy in patients with advanced colorectal carcinoma previously treated with 5-FU.

  1982cites this paper
• Combination chemotherapy of advanced colorectal cancer utilizing 5‐fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: A phase III trial by the eastern cooperative oncology group (EST: 4275)

  1982cites this paper
• Chemotherapy following palliative resection of gastric cancer

  1981cites this paper
• Chemotherapy of human colorectal tumor xenografts in athymic mice with clinically active drugs: 5‐fluorouracile and 1‐3‐bis‐(‐2‐chloroethyl)‐1‐nitrosourea (bcnu). Comparison with doxorubicin derivatives: 4′deoxydoxorubicin and 4′‐0‐methyldoxorubicin

  1981cites this paper
• Evaluation of beta-2'-deoxythioguanosine combined with methyl-CCNU or mitomycin in advanced colorectal cancer. A Southwest Oncology Group study.

  1981cites this paper
• Comparison of ftorafur with 5-fluorouracil in combination chemotherapy of advanced gastrointestinal carcinoma.

  1981cites this paper
• Chemotherapy of Pancreatic, Colorectal and Gastric Cancer

  1981cites this paper
• Recent results of clinical therapeutic trials for gastrointestinal malignancies conducted in the United States.

  1981cites this paper
• The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced gastrointestinal malignancy.

  1981cites this paper
• Phase II study of PCNU in colorectal carcinoma.

  1981cites this paper
• Phase I trial of chlorozotocin: attempted amelioration of myelotoxicity by glucose administration.

  1981cites this paper
• Chemotherapy for colorectal cancer with a combination of PALA and 5-FU.

  1981cites this paper
• Methyl-CCNU, 6-thioguanine, and 5-fluorouracil in advanced colorectal cancer.

  1981cites this paper
• Chemotherapy in alimentary tract malignomas.

  1981cites this paper
• Phase II study of chlorozotocin in non-small cell carcinoma of the lung.

  1981cites this paper
• Gastric adenocarcinoma.

  1980cites this paper
• Metastatic colorectal cancer. Combination chemotherapy in patients previously treated with 5-fluorouracil.

  1980cites this paper
• Combination chemotherapy in advanced gastrointestinal malignancy.

  1980cites this paper
• [Therapeutic progress in digestive system neoplasms. VII. Treatment of pancreatic neoplasms].

  1980cites this paper
• Chlorozotocin, an anti-tumour agent lacking bone marrow toxicity at therapeutic doses: effects on lymphocyte subpopulations in mice.

  1980cites this paper
• Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin

  1979cites this paper
• Effects of CCNU on hematopoiesis in rats.

  1979cites this paper
• Chemotherapy of pancreatic cancer.

  1979cites this paper
• A structure--activity study of seven new water soluble nitrosoureas.

  1979cites this paper
• A phase I study of chlorozotocin (NSC 178248)

  1979cites this paper
• Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.

  1979cites this paper
• Response of exponentially growing, stationary-phase, and synchronized cultured human colon carcinoma cells to treatment with nitrosourea derivatives.

  1979cites this paper
• Alterations in the toxicity and antitumor activity of methyl-CCNU in mice following pretreatment with either phenobarbital or SKF 525A.

  1979cites this paper
• Antitumor activity of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea (MeCCNU) on yoshida sarcoma ascites cells implanted into the colon wall of rats

  1979cites this paper
• [Clinical and therapeutic study (phase II) using VP-16/213 and methyl-CCNU in patients with inoperable, recurring or metastasizing carcinomas of the gastriointestinal tract].

  1978cites this paper
• Sequential chemoimmunotherapy of colorectal cancer. Evaluation of methotrexate, Baker's antifol and levamisole

  1978cites this paper
• Treatment of gastric carcinoma. New perspective.

  1978cites this paper
• Biological and biochemical properties of the 2-hydroxyl metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.

  1978cites this paper
• Chemotherapy and chemoimmunotherapy of colorectal cancer. Role of the carcinoembryonic antigen.

  1978cites this paper
• Phase II trial of streptozotocin, mitomycin‐C and 5‐fluorouracil (SMF) in the treatment of advanced pancreatic cancer

  1978cites this paper
• [Chemotherapy of gastrointestinal tumors (review of the literature)].

  1978cites this paper
• Combination chemotherapy against B 16 melanoma: bleomycin/vinblastine, bleomycin/cis‐diamminedichloroplatinum, 5‐fluorouracil/BCNU and 5‐fluorouracil/methyl‐CCNU

  1978cites this paper
• Differential repair of 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea-induced DNA damage in two human colon tumor cell lines.

  1978cites this paper
• Qualitative and quantitative toxicity of sublethal doses of methyl-CCNU in BDF1 mice.

  1977cites this paper
• Management of gastrointestinal cancer.

  1977cites this paper
• A structure-activity analysis of chemical and biological parameters of chloroethylnitrosoureas in mice.

  1977cites this paper
• Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.

  1977cites this paper
• Structure-activity studies of methylnitrosourea antitumor agents with reduced murine bone marrow toxicity.

  1977cites this paper
• Iv methyl-CCNU and ftorafur with or without methanol-extracted residue of BCG for metastatic adenocarcinoma of the colon.

  1977cites this paper
• Gastric cancer: current status of treatment.

  1977cites this paper
• Review of literature on diseases of the colon and rectum

  1977cites this paper
• Mitomycin C: a review.

  1976cites this paper
• Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5‐FU vs. methyl‐CCNU plus bolus weekly 5‐FU. A southwest oncology group study

  1976cites this paper
• Phase II study of methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.

  1976cites this paper